10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average.
Evoke Pharma Inc (EVOK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 148,194 | $655,017 | +164% | 0.02% |
| 2. | Corsair Capital Management Jay Petschek And Steven Major | 0 | $0 | -100% | 0% |
| 3. | AIGH Investment Partners Orin Hirschman | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.35 | 11,628 | Large Shareholder | 48,449 | 2018-08-20 | Filing | |
| $2.35 | 23,256 | Large Shareholder | 96,897 | 2018-08-20 | Filing | |
| $2.35 | 465,116 | Large Shareholder | 1,937,983 | 2018-08-20 | Filing | |
| $2.90 | 10,465 | Director | 36,821 | 2017-02-22 | Filing | |
| $2.90 | 20,930 | Director | 73,641 | 2017-02-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.39 | 41 | Large Shareholder | 148,153 | 2025-01-28 | Filing | |
| $2.94 | 23,954 | Officer, Director | 339,782 | 2020-12-14 | Filing | |
| $2.90 | 48,046 | Officer, Director | 363,736 | 2020-12-11 | Filing | |
| $2.91 | 40,357 | Officer | 283,997 | 2020-12-11 | Filing | |
| $2.95 | 5,643 | Officer | 324,354 | 2020-12-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 68,750 | $303,875 | 0.07% | |
| 2. | 1,258 | $5,560 | 0% | |
| 3. | 122 | $539 | 0% | |
| 4. | 75 | $332 | 0% | |
| 5. | 31 | $137 | 0% |
News See All
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc.
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Evoke Pharma's Fourth Quarter and Full Year 2022 Earnings Conference Call.
Here's What's Next For Evoke Pharma Inc (EVOK)
Evoke Pharma Inc (NASDAQ:EVOK) is running up on news of a successful meeting with the FDA, during which the company got confirmation of what amounts to a streamlined path to commercialization for its ...
A Look at Five Stocks on Investors' Radars on Tuesday
Among the stocks that are trending on Tuesday are The Hain Celestial Group, Inc.
Tempur Sealy (TPX), GrubHub (GRUB), United States Steel Corporation (X) Among Top Weekly Gainers
It was a mixed week for the market last week, as the Dow gave up 0.75% of its value, while the S&P 500 was down slightly, and the Nasdaq was 1.21% in the green.
Thursday's White-Hot Stocks: Evoke Pharma, GrubHub, Logitech, More
Stocks are wavering on Thursday following a rise in weekly jobless claims, a widening trade deficit, and mixed earnings reports.
Why GlaxoSmithKline, Groupon, Lending Club And 2 Micro-Caps Are Trending Today
The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp (NYSE:LC), Ballard Power...
Here is What Hedge Funds Think About Evoke Pharma Inc (EVOK)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
What Do The World's Greatest Investors Think of These Hot Biotech Stocks?
Sarepta Therapeutics Inc (NASDAQ:SRPT), Pacific Biosciences of California (NASDAQ:PACB), and Evoke Pharma Inc (NASDAQ:EVOK) are trending today as their shares are up by 22%, 44%, and 11.8% respectively...
Billionaire Hedge Funds
